Literature DB >> 6193346

Serum lipoproteins and indices of glucose tolerance during diuretic therapy: a comparison between hydrochlorothiazide and piretanide.

M Välimäki, K Harno, E A Nikkilä.   

Abstract

Two diuretic drugs, hydrochlorothiazide (HCT) and piretanide (PT), were compared for their effects on plasma lipoproteins and glucose tolerance in 24 hypertensive male subjects over a period of 12 weeks. In comparison with preceding placebos, both drugs caused an increase of total cholesterol, low-density lipoprotein (LDL) cholesterol, total triglyceride, and very-low-density lipoprotein (VLDL) triglyceride concentrations, whereas no significant change occurred in high-density lipoprotein (HDL) cholesterol. The alterations were partly reversible in patients receiving HCT. Apoprotein A and B concentrations were increased by PT but were little influenced by HCT. Also, the LDL/HDL cholesterol ratio was increased during PT. Neither drug invariably influenced the postheparin plasma lipase activities, oral glucose tolerance, plasma insulin levels, or insulin binding to red cells. The results suggest that diuretic drugs may promote the hepatic secretion of VLDL. The mechanism of this action remains to be established, and the clinical relevance of these findings is still not clearly understood.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193346     DOI: 10.1097/00005344-198307000-00003

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

Review 2.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

Review 3.  The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

4.  Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.

Authors:  W R McNabb; F H Noormohamed; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

5.  Effects of a new diuretic piretanide on glucose tolerance, insulin secretion and 125I-insulin binding.

Authors:  K Harno; M Välimäki; M Verho
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.